MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...

In a case of consolidation in the Chinese pharma sector, LaNova Medicines is being bought out by minority shareholder Sino Biopharm in a deal valued at around $951 million. Under the terms of the deal ...

Ukrainian strikes on Russian oil facilities could be a boon for US refiners The recent wave of Ukrainian drone attacks on Russian oil refineries and export facilities could boost global refining ...

How do babies manage to let their parents know what they want, when they haven't yet learnt to speak? Is there a reason behind their seemingly random movements? Neil and Beth discuss this and teach ...